The combined application of CTX and oxalate showed a synergistic inhibition effect to inhibit the viability of CTX-resistant cells, suggesting that LDHA inhibition may be an effective sensitizer for the treatment of cancer resistance (57). The gene discussed is LDHA; the disease is cancer.